tetano
Editor, Senior Moderator
Clin Dermatol
. Sep-Oct 2021;39(5):920-926.
doi: 10.1016/j.clindermatol.2020.12.003. Epub 2020 Dec 14.
COVID-19-related skin manifestations: Update on therapy
Laura Atzori[SUP] 1 [/SUP], Sebastiano Recalcati[SUP] 2 [/SUP], Caterina Ferreli[SUP] 3 [/SUP], Leonard J Hoenig[SUP] 4 [/SUP], Franco Rongioletti[SUP] 5 [/SUP]
Affiliations
Abstract
An increasing body of evidence has been produced in a very limited period to improve the understanding of skin involvement in the current coronavirus 2019 disease pandemic, and how this novel disease affects the management of dermatologic patients. A little explored area is represented by the therapeutic approach adopted for the different skin manifestations associated with the infection. An overview of the current scenario is provided, through review of the English-language literature published until October 30, 2020, and comparison with the personal experience of the authors. As dermatologists, our primary aim is to support patients with the highest standard of care and relieve suffering, even with lesions not life-threatening. With asymptomatic COVID-19 patients, patient discomfort related to skin lesions should not be undervalued and intervention to accelerate healing should be provided. Consensus protocols are warranted to assess the best skin-targeted treatments in COVID-19 patients.
. Sep-Oct 2021;39(5):920-926.
doi: 10.1016/j.clindermatol.2020.12.003. Epub 2020 Dec 14.
COVID-19-related skin manifestations: Update on therapy
Laura Atzori[SUP] 1 [/SUP], Sebastiano Recalcati[SUP] 2 [/SUP], Caterina Ferreli[SUP] 3 [/SUP], Leonard J Hoenig[SUP] 4 [/SUP], Franco Rongioletti[SUP] 5 [/SUP]
Affiliations
- PMID: 34785023
- DOI: 10.1016/j.clindermatol.2020.12.003
Abstract
An increasing body of evidence has been produced in a very limited period to improve the understanding of skin involvement in the current coronavirus 2019 disease pandemic, and how this novel disease affects the management of dermatologic patients. A little explored area is represented by the therapeutic approach adopted for the different skin manifestations associated with the infection. An overview of the current scenario is provided, through review of the English-language literature published until October 30, 2020, and comparison with the personal experience of the authors. As dermatologists, our primary aim is to support patients with the highest standard of care and relieve suffering, even with lesions not life-threatening. With asymptomatic COVID-19 patients, patient discomfort related to skin lesions should not be undervalued and intervention to accelerate healing should be provided. Consensus protocols are warranted to assess the best skin-targeted treatments in COVID-19 patients.